Novo Nordisk registers Phase 3 zenagamtide trial in T2D and first-in-human study for NNC0705-0002Sep 1Weekly roundup, 2 itemsNNC0705-0002Novo Nordisk A/S
Novo Nordisk posts Phase 3 icodec vs. glargine results; registers two observational studiesJul 2Weekly roundup, 3 itemsinsulin icodecNovo Nordisk A/S
Sign inSign in